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Understanding how neuronal activity patterns in the brain correlate with complex
behavior is one of the primary goals of modern neuroscience. Chemical transmission
is the major way of communication between neurons, however, traditional methods
of detection of neurotransmitter and neuromodulator transients in mammalian brain
lack spatiotemporal precision. Modern fluorescent biosensors for neurotransmitters
and neuromodulators allow monitoring chemical transmission in vivo with millisecond
precision and single cell resolution. Changes in the fluorescent biosensor brightness
occur upon neurotransmitter binding and can be detected using fiber photometry,
stationary microscopy and miniaturized head-mounted microscopes. Biosensors can
be expressed in the animal brain using adeno-associated viral vectors, and their
cell-specific expression can be achieved with Cre-recombinase expressing animals.
Although initially fluorescent biosensors for chemical transmission were represented
by glutamate biosensors, nowadays biosensors for GABA, acetylcholine, glycine,
norepinephrine, and dopamine are available as well. In this review, we overview
functioning principles of existing intensiometric and ratiometric biosensors and provide
brief insight into the variety of neurotransmitter-binding proteins from bacteria,
plants, and eukaryotes including G-protein coupled receptors, which may serve as
neurotransmitter-binding scaffolds. We next describe a workflow for development of
neurotransmitter and neuromodulator biosensors. We then discuss advanced setups
for functional imaging of neurotransmitter transients in the brain of awake freely moving
animals. We conclude by providing application examples of biosensors for the studies
of complex behavior with the single-neuron precision.
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INTRODUCTION
Neurotransmitters and neuromodulators are chemicals, which are crucial for signal transmission
in neuronal circuits. Neurotransmitters are released by the axon of the presynaptic neuron and
excite, like glutamate, or inhibit, like γ-aminobutyric acid (GABA), the adjacent neurons in a
sub-second timescale. Neurotransmitters are stored in vesicles in presynaptic terminals and are
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released into the synaptic cleft in response to an action potential
(Figure 1A; Klein et al., 2019). Neuromodulators are diffusing
chemicals that modulate activity of the groups of neurons and can
act not only on fast but also on slow timescales (Figures 1B,C).
However, even classical fast neurotransmitters, such as glutamate,
may not necessarily act as point-to-point transmitters; and
diffusion of neurotransmitters from the synaptic cleft to the
extracellular space is sufficient to activate non-synaptic receptors
at a significant distance. This type of neurotransmission is called
volumetric transmission (Taber and Hurley, 2014).
Neurotransmitters act on ionotropic and metabotropic
receptors. Ionotropic receptors are ion channels whose activity
is directly modulated by neurotransmitters. As an example,
glutamate interaction with its ionotropic receptors (iGluRs)
at the plasma membrane of the post-synaptic neurone leads
to opening of channel pores, cation influx and membrane
depolarization (Figure 1C; Traynelis et al., 2010). Metabotropic
receptors are G-protein-coupled receptors (GPCRs) and their
activation by neurotransmitters leads to indirect modulation
of ion channels activity via activation of G-protein signaling
(Nadim and Bucher, 2014).
Neuromodulators act mostly through G-protein-coupled
receptors (Figure 1C; Nadim and Bucher, 2014; Avery
and Krichmar, 2017), however, clear distinction between
neurotransmitters and neuromodulators is problematic, as far
as many classical neuromodulators may act through ionotropic
receptors. For example, acetylcholine acts mostly as point-
to-point neurotransmitter at neuromuscular junctions and in
peripheral nervous system but as neuromodulator in central
nervous system (Picciotto et al., 2012).
While neurotransmission leads to the fast excitation or
inhibition of the post-synaptic neurons, neuromodulation results
in the alteration of synaptic efficacy and in the changes of
synaptic dynamics. Action of neuromodulators can change
the rates of depression and facilitation at synapses, allowing
synaptic dynamics as well as strength to vary (Nadim and
Bucher, 2014). In the nervous system neuromodulators regulate
switching of brain states, with the examples of serotonin
controlling mood and norepinephrine controlling sleep and
arousal (Avery and Krichmar, 2017).
All neurotransmitters and neuromodulators are essential to
cognition and behavior (Nadim and Bucher, 2014; Avery and
Krichmar, 2017). The correlation of chemical transmission
in animal brain with its complex behavior can be studied
using modern fluorescent biosensors. These biosensors provide
high spatiotemporal precision for the visualization of fast
neurotransmitter transients in neural circuits in brains of
behaving animals (Brunert et al., 2016; Xie et al., 2016; McGirr
et al., 2017; Sun et al., 2018; Tanaka et al., 2018; Feng et al., 2019;
Marvin et al., 2019).
Fluorescent proteins (FPs) are essential part of modern
biosensors. There are two major approaches of using FPs in
biosensors. The first approach employs Forster resonance energy
transfer (FRET) between two FPs (Li et al., 2016). FRET
occurs when a donor FP is excited by light and non-radiatively
transfers the excitation energy to the nearby chromophore, an
acceptor. The second approach employs circular permutants
of FPs (cpFPs) (Wang et al., 2018). Circular permutation
involves rearrangement of the parts of the original FP that
retains the protein secondary structure. Certain regions in cpFPs
tolerate insertion of other proteins; and conformational changes
in the insert profoundly influence the fluorescence intensity.
Moreover, circular permutants alter the relative orientation of
the chromophore to a fusion partner, which is exploited in the
optimization of FRET-based biosensors by inserting cpFPs.
Fluorescent biosensors can be delivered to the animal brain
using viral vectors and detected in behaving animals by fiber
photometry, including multi-channel fiber photometry (Guo
et al., 2015), stationary two-photon (2P) excitation microscopy
(Svoboda and Yasuda, 2006), and miniaturized head-mounted
microscopes (Aharoni et al., 2019). Imaging of neurotransmitter
transients in response to visual, audio or olfactory stimuli can
be performed in restrained animals, however, head-mounted
wireless miniaturized microscopes allow imaging of biosensors
in the brain of freely moving animals (Liberti et al., 2017).
In this review, we firstly summarize available fluorescent
biosensors for neurotransmitters and neuromodulators. We then
outline a biosensor engineering workflow and provide the
basic design principles for the modern biosensors. Next, we
overview detection and functional imaging techniques that allow
recording neurotransmitter and neuromodulator transients in
animals. We then discuss how the biosensors enable monitoring
brain function with high spatiotemporal precision and how
they can be combined with common optogenetic tools for
all-optical electrophysiology assays. Lastly, we outline avenues
for engineering and applications of future biosensors for
neurotransmitters and neuromodulators.
For biosensors of neural activity, such as genetically encoded
membrane voltage and calcium indicators, we refer our readers to
the recent reviews (Chen et al., 2017; Bando et al., 2019; Kannan
et al., 2019; Piatkevich et al., 2019).
GENERAL DESIGNS OF BIOSENSORS
FOR CHEMICAL TRANSMISSION
To develop fluorescent biosensor for neurotransmitter or
neuromodulator, a FRET pair of FPs or a cpFP is combined with
a respective binding protein, called a sensing domain. In FRET-
based biosensors a ratio between fluorescence intensities of the
FRET donor and FRET signal changes upon neurotransmitter
binding, therefore they are referred as ratiometric biosensors.
In single-FP-based biosensors, fluorescence at single wavelength
changes upon neurotransmitter binding, therefore they are
referred as intensiometric biosensors (Lindenburg and Merkx,
2014; Chen et al., 2017). Currently, two types of sensing
domains are used for engineering of both ratiometric and
intensiometric biosensors.
First, periplasmic-binding proteins (PBPs) that interact with
neurotransmitters are used. PBPs possess so-called Venus Flytrap
Domain (VFTD), which changes its conformation upon binding
neurotransmitter. VFTD is a bilobal protein, which remains
“open” in the inactive state and “closes” upon ligand binding
(Figure 2; Kunishima et al., 2000; Pin et al., 2003). At the
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FIGURE 1 | Neurotransmission and neuromodulation principles. (A) In local neurotransmission, neurotransmitters packed in vesicles are released into the synaptic
cleft and interact with the ionotropic receptors of neurotransmitters, which are typically ion channels. The interaction causes receptor with inhibitory or excitatory
neurotransmitter channel to open to negatively or positively charged ions. The post-synaptic neuron is inhibited (blue) or excited (red). Neurotransmitters released by
a presynaptic neuron act only on the single post-synaptic neuron and, after interaction with ionotropic receptors, are rapidly destroyed in the synaptic cleft. (B) In
neuromodulation and volumetric transmission, neuromodulators released by a single neuron act simultaneously on the groups of neurons, modulating their synaptic
strength. (C) Neurotransmission at synaptic level: on the left: the inhibitory neurotransmitter is released in the synaptic cleft and activates anion channels and GPCR
receptors. Activation of GPCR receptors by the inhibitory neurotransmitters, such as GABA, negatively regulates calcium channels. On the right: the excitatory
neurotransmitter is released in the synaptic cleft and activates cation channels and relevant GPCR receptors.
moment only three PBP proteins, such as GltI from Escherichia
coli, Atu2422 from Agrobacterium tumefaciens, and Pf622 from
Pseudomonas fluorescens are used in the neurotransmitter
biosensors (Table 1). In PBP-based biosensors VFTD domain is
inserted into the FRET pair (Figure 2A; Chen et al., 2017) or, on
the contrary, cpFP is inserted into the flexible region of VFTD
domain (Figure 2C; Marvin et al., 2013). Upon neurotransmitter
binding, VFTD domain changes its structure from “open” to
“closed” and that results in the either FRET between fluorescent
proteins or restoration of the cpFP fluorescence, if cpFP is used.
Glutamate, acetylcholine, serotonin and GABA binding-
proteins were discovered in organisms lacking nervous systems
and even in unicellular organisms (Venter et al., 1988; Hoyle,
2011; Elphick et al., 2018). Bacteria use neurotransmitter-
recognizing motifs presented by PBPs (Moussatova et al., 2008)
in ATP binding cassette (ABC) transporters (Wilkens, 2015),
with an example of several glutamine, L-histidine, glycine,
and arginine-binding transporters (Moussatova et al., 2008).
Moreover, the family of plant glutamate-receptor like proteins
might become a source of neurotransmitter-binding motifs.
Proteins of this family bind GABA and various amino acids, such
as glycine and glutamate (Forde and Roberts, 2014). AtGAT1, a
high-affinity GABA transporter in Arabidopsis thaliana may also
present a valuable scaffold for engineering of GABA biosensors
(Meyer et al., 2006). Dopamine/norepinephrine transporter
(SmDAT) (Larsen et al., 2011), as well as transporters of serotonin
and norepinephrine (Ribeiro and Patocka, 2013), were found in
human parasite trematode Schistosoma mansoni.
Second, GPCRs are used for the development of
neurotransmitter and neuromodulator biosensors. GPCRs are
membrane-spanning proteins, which change their conformation
upon binding of neurotransmitters or neuromodulators and
activate downstream signaling (Niswender and Conn, 2010).
In this type of biosensors the activation state of GPCR is
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FIGURE 2 | Ratiometric and intensiometric biosensors. (A) FRET-based biosensors in which PBP proteins are used as neurotransmitter-sensing domains. A PBP is
inserted between FRET pair of FPs, such as ECFP and mVenus. Upon PBP interaction with neurotransmitter the FRET efficiency between FPs changes, which can
be detected. (B) FRET-based biosensors in which GPCR receptors are used as neurotransmitter-sensing domains. A FRET pair consisting of ECFP and mVenus is
inserted in the third intracellular loop of the respective GPCR. Upon interaction of the receptor with neurotransmitter FRET between two FPs changes. (C) Example
of the PBP-based intensiometric biosensor is shown. Circular permutant of superfolder GFP (sfGFP) between positions 146–147 is inserted into GltI protein, resulting
in the SF-iGluSnFR glutamate biosensor (Marvin et al., 2018). N-terminal IgG-secretion signal ensures transport of the biosensor to extracellular space, while
C-terminal transmembrane domain of PDGFR receptor anchors the biosensor to the plasma membrane (D) Example of the GPCR-A-based intensiometric biosensor
is shown. Circularly permuted EGFP (cpEGFP) is inserted into the third intracellular loop of GPCR having the VFTD domain at the N-terminus. After binding
neurotransmitter or neuromodulator, the conformation of GPCR changes that results in enhancement of cpEGFP fluorescence.
detected. Neurotransmitters and neuromodulators mostly
interact with GPCRs of the A group (GPCR-A), with the
exception of glutamate and GABA, which interact with the
GPCRs of the C group (GPCR-C), such as metabotropic
glutamate receptors and GABA receptors. GPCR-C receptors
possess the large N-terminal domain, which is structurally
similar to the VFTD of PBPs. Similar to VFTDs of GltI and
Atu2422, the VFTD of GPCR-C remains “open” in the inactive
state and “closes” upon neurotransmitter binding (Figure 2B).
Second and third intracellular loops of GPCR-C receptors
form the cavity, responsible for the G-protein recognition
(Pin et al., 2003). The GPCR-A group comprises all other
receptors of neurotransmitters and neuromodulators, including
catecholamine aminergic receptors, β-adrenergic receptors,
histamine H1 receptor and muscarinic acetylcholine receptors
(Katritch et al., 2013). As opposed to GPCR-C receptors,
GPCR-A receptors have the longer intracellular third domain
(it is the longest intracellular domain in these receptors, while
in GPCR-Cs the second domain is the longest) and do not
have VFTD domain.
In both GPCR-A- and GPCR-C-based neurotransmitter
biosensors, a FRET pair of FPs (Figure 2B) or a cpFP (Figure 2D)
is inserted in a third intracellular loop of the receptor (Sun et al.,
2018; Wang et al., 2018; Feng et al., 2019). Upon neurotransmitter
binding to the extracellular part of the GPCR, the receptor
conformational changes are transferred to the intracellular part,
causing the FRET changes between FPs or the recovery of
cpFP fluorescence.
Below we describe the modern biosensors for
neurotransmitters and neuromodulators, which are compatible
with the studies of chemical transients in the brain of
behaving animals.
BIOSENSORS FOR GLUTAMATE
Glutamate is the most abundant excitatory neurotransmitter in
the mammalian nervous system. Concentration of glutamate is
tightly regulated by the number of transporters and glutamate-
degrading enzymes, preventing the glutamate excitotoxicity
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TABLE 1 | Modern biosensors for neurotransmitters and neuromodulators.
FRET-based
biosensors
FRET pair Relative change of
FRET ratio,1R/R (%)
Kd (µM) Conditions used to
measure 1R/R and Kd
Substance
(neurotransmitter or
neuromodulator)
Template for sensing
domain
In vivo use References
SuperGluSnFR ECFP-Citrine 44 2.5 Cultured neurons, 1P
microscopy
Glutamate GltI Not tested Hires et al.,
2008
M1-cam5 ECFP-EYFP 10 Not determined HEK293 cells, 1P
microscopy
Acetylcholine M1mAChR Markovic et al.,
2012
GlyFS EGFP-Venus 20 20 Brain slices, 2P microscopy Glycine Atu2422 (AYW mutant) Zhang et al.,
2018
Single-FP-based
biosensors
Circularly
permuted FP
Relative change of
fluorescence,1F/F (%)
Kd (µM) Conditions used to
measure 1F/F and Kd
Substance
(neurotransmitter or
neuromodulator)
Template for sensing
domain
In vivo use References
iGluSnFR cpGFP 103 4.9 Cultured neurons, 1P
microscopy
Glutamate GltI Imaging of dendritic
spines
Marvin et al.,
2013
SF-iGluSnFR
A184V
sfGFP 69 0.6 Marvin et al.,
2018
SF-iGluSnFR S72A 250 34
SF-Azurite-
iGluSnFR
Azurite 66 46
SF-Venus-iGluSnFR Venus 66 2
SF-mTurquoise2-
iGluSnFR
mTurquoise 90 41
iGABASnFR sfGFP 250 9 Purified protein, fluorimeter GABA Pf622 Imaging of single
neurons
Marvin et al.,
2019
iGluf EGFP 100 137 HEK293 cells,
stopped-flow
Glutamate GltI Not tested Helassa et al.,
2018
iGluu 170 600
R-iGluSnFR1 mApple −33 11 Purified protein, fluorimeter Wu et al., 2018
R-ncp-iGluSnFR1 0.9
GACh EGFP 90 2 HEK293 cells, 1P
microscopy
Acetylcholine M3R Imaging of single
neurons
Jing et al.,
2018
GRABNE1m 230 1.9 Norepinephrine α2AR Aggregated
fluorescence signal
Feng et al.,
2019
GRABNE1h 150 0.093
Nb80-GFP Not determined Not determined Not applicable β2AR/Nb80 Not tested Irannejad et al.,
2013
OR-sensor EGFP Not determined Not determined Not applicable Activation of µ and δ
ORs
µ and δ ORs/Nb33 Not tested Stoeber et al.,
2018
iATPSnFR spGFP 150 630 Cultured neurons, 1P
microscopy
ATP ε subunit of FOF1
ATPase from Bacillus
PS3
Imaging of single
astrocytes
Lobas et al.,
2018
dLight1.1 EGFP 230 0.33 HEK293 cells, 1P
microscopy
Dopamine DRD1 (inserted into the
ICL3)
Aggregated
fluorescence signal
Patriarchi et al.,
2018
dLight1.2 340 0.77
DA1m 90 0.13 DRD2 (inserted into the
ICL3)
Sun et al., 2018
DA1h 0.01
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(Zhou and Danbolt, 2014). Glutamate is released not only
by neurons but also by glial cells (Harada et al., 2015).
As it has been mentioned, glutamate-binding proteins are
found in all kingdoms of life (Pin et al., 2003; Ribeiro
and Patocka, 2013; Forde and Roberts, 2014). Some of these
proteins, such as GltI, are similar to extracellular VFTD
domains of mammalian GPCR-C receptors of glutamate and
GABA (Figure 2A).
The first glutamate ratiometric biosensor was based on the
GltI inserted between the ECFP-mVenus FRET pair of proteins
(Okumoto et al., 2005). It was later improved by replacing
mVenus with EYFP and systematic screening for the highest
glutamate sensitivity. This resulted in SuperGluSnFR biosensor
(Table 1) that exhibits 44% change in FRET/donor ratio upon
glutamate binding (Hires et al., 2008).
Later, an intensiometric glutamate sensor, iGluSnFR,
was engineered by inserting of cpEGFP in GltI (Figure 2C;
Marvin et al., 2013). Although iGluSnFR was shown to
work in vivo, it has some limitations including slow readout
of glutamate dynamics in synapses and inability to detect
sparse glutamate release (Marvin et al., 2018). iGluSnFR
was recently improved by developing two fast glutamate
biosensors iGluu and iGluf (Helassa et al., 2018). Reducing
the GltI affinity to glutamate enabled increasing rate of
its dissociation in iGluu and iGluf. Another family of
glutamate biosensors was developed by replacing cpEGFP
in iGluSnFR with circularly permuted superfolder GFP
(fGFP) (Marvin et al., 2013). Moreover, iGluSnFR affinity to
glutamate was changed by mutating GltI in the ligand-binding
center. This resulted in two biosensors, SF-iGluSnFRS72A
and SF-iGluSnFRA184V, with the reduced and enhanced
affinity to glutamate, respectively. To develop multicolor
SF-iGluSnFR biosensors, Marvin et al. (2018) introduced in
the cpsfGFP chromophore mutations from spectrally-shifted
GFP variants, such as mAzurite, mTurquoise2 and mVenus,
resulting in the blue, cyan and yellow SF-GluSnFRA184V
variants, respectively.
To shift intensiometric glutamate biosensors toward red
spectral range, cpEGFP in iGluSnFR was replaced with circularly
permuted mApple red FP, resulting in R-iGluSnFR1 and R-ncp-
iGluSnFR1 biosensors (Wu et al., 2018). Although R-iGluSnFR1
exhibits the high glutamate affinity and dynamic range (Table 1;
Wu et al., 2018), it demonstrates the fluorescence decrease
upon glutamate binding, as opposed to the glutamate biosensors
based on the GFP variants. It makes R-iGluSnFR1 rather
similar to “turn-off” quantum dots used in neurotransmitter
research, which lose fluorescence upon neurotransmitter binding
(Ankireddy and Kim, 2015). Red fluorescent biosensors for
glutamate which respond to glutamate binding with fluorescence
increase are still waiting to be developed.
GABA BIOSENSORS
While glutamate is the primary excitatory neurotransmitter in
the brain, GABA is the main inhibitory neurotransmitter. GABA
interacts with the GPCR-C receptors. While the earlier GABA
biosensors were “semisynthetic” (Masharina et al., 2012; Lecat-
Guillet et al., 2017), recently, a fully genetically encoded GABA
biosensor was developed (Marvin et al., 2019).
The first GABA semisynthetic biosensor, called GABA-Snift
(Masharina et al., 2012), is based on the GABAB receptor in
which VFTD is N-terminally fused to the CLIP and SNAP tag
peptide sequences. The SNAP and CLIP tags interact with the
synthetic fluorophores forming a FRET pair. Moreover, in the
GABA-Snift an antagonist of GABA, CGP71783, occupies a cleft
between the lobes of the VFTD. When the cleft is occupied
by CGP71783, FRET between synthetic fluorophores is weak;
however, when GABA displaces CGP71783 the FRET enhances
(Masharina et al., 2012). Another semisynthetic biosensor reports
conformational changes in the heterodimeric GABAB receptor
that consist of GB1 and GB2 subunits. Similarly to GABA-Snift, in
the GABAB receptor-based biosensor the SNAP and ACP peptide
tags are used. These tags are attached to VFTDs of the different
GABAB subunits. Fluorescein and Lumi4-Tb fluorophores bind
the SNAP and ACP tags, respectively (Masharina et al., 2012;
Lecat-Guillet et al., 2017).
The semisynthetic biosensors need adding of fluorophores,
which complicates their use in vivo. Recently, a GABA-
recognizing Pf622 protein from non-sequenced Pseudomonas
fluorescens strain was used to engineer an intensiometric GABA
biosensor, named iGABASnFR. In iGABASnFR, cpsfGFP is
inserted into the Pf622 protein. As the membrane-anchoring
sequences iGABASnFR utilizes an N-terminal immunoglobulin
secretion signal and a C-terminal transmembrane domain of
the platelet-derived growth factor receptor (PDGFR) (Marvin
et al., 2019). Similarly to SF-iGluSnFR biosensor, iGABASnFR
demonstrated good membrane localization, however, its response
to neurotransmitter release was almost 10-fold smaller than of
SF-iGluSnFR. In hippocampal acute slices, iGABASnFR detected
GABA release caused by electric stimulation of stratum radiatum
with sufficient signal-to-noise ratio. Yet, reliable recording of
GABA release from individual synapses using iGABASnFR was
challenging, whereas release of glutamate at individual synapses
was easily detectable with SF-iGluSnFR.
ACETYLCHOLINE BIOSENSORS
Acetylcholine acts as fast point-to-point neurotransmitter
in the peripheral nervous system and in neuromuscular
junctions and as neuromodulator acting on the groups of
neurons in the central nervous system. It is responsible for
the adaptive behavior and coordinates responses of neuronal
circuits in many brain areas (Picciotto et al., 2012). As a
neuromodulator, acetylcholine influences neuronal excitability,
synaptic transmission and synaptic plasticity. Moreover,
acetylcholine coordinates firing of groups of neurons (Picciotto
et al., 2012). It acts through the nicotinic receptors (nAchR),
which are non-selective cationic channels, and muscarinic
receptors (mAChR), which are GPCRs (Markovic et al.,
2012) coupled to either Gq proteins (M1, M2, and M5
subtypes) activating phospholipase C or Gi/o proteins (M2
and M4 subtypes) inhibiting adenylate cyclase (Wess, 2003;
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 October 2019 | Volume 13 | Article 474
fncel-13-00474 October 21, 2019 Time: 15:32 # 7
Leopold et al. Fluorescent Biosensors for Neurotransmission and Neuromodulation
Picciotto et al., 2012). Acetylcholine can act as inhibitory and
excitatory neuromodulator, depending on the localization
and type of muscarinic receptors. Action of acetylcholine on
presynaptic mAChRs (M2/M4) is inhibitory whereas action
on post-synaptic muscarinic receptors (M1/M5) is activatory
(Picciotto et al., 2012). Action of acetylcholine on nicotinic
ionotropic receptors in the brain is mostly neuromodulatory
because nAChRs predominantly participate in coordination of
neuronal firing (Picciotto et al., 2012).
M1-mAchR was used to develop the first genetically
encoded acetylcholine biosensor. A FRET-based acetylcholine
biosensor was engineered by inserting ECFP and EYFP
into the third intracellular loop of the mouse M1-mAChR
receptor. The resulting biosensor, called M1-cam5, retained
the ability to stimulate downstream signaling of M1-mAchR
(Markovic et al., 2012).
mAchRs were also used to develop intensiometric biosensors.
For this, the longest third intracellular loop of mAchRs
was replaced with the shorter third intracellular loop from
the β2 adrenergic receptor, and cpEGFP was inserted in it,
following random mutagenesis of the N- and C-termini of
cpEGFP. After the first round of mutagenesis Jing et al.
(2018) identified several best clones producing up to ∼70%
fluorescence increase upon acetylcholine binding. The mutations
from the found clones were rationally combined and the best
biosensor variant was called GACh2.0 (Jing et al., 2018). In
contrast to ratiometric M1-cam5 biosensor (Markovic et al.,
2012) GACh2.0 exhibits weak coupling to downstream G-protein
intracellular signaling, likely due to the replacement of mAchR
third intracellular loop with the respective intracellular loop of
the β2 adrenergic receptor.
Recently, the acetylcholine synthesis pathway was described
in unicellular eukaryotes Acanthamoeba sp. (Baig et al., 2018).
Earlier, a mAChR1 homolog was identified in Acanthamoeba
castellanii (Baig and Ahmad, 2017). Likely, these unicellular
eukaryotes can become a source of acetylcholine-binding
domains for the development of novel acetylcholine biosensors.
DOPAMINE BIOSENSORS
Dopamine is primarily involved in the reward behavior, control of
movement, emotion and cognition. Dysfunction of dopaminergic
system is the cause of several mental disorders including
Parkinsonism and autism spectrum disorder. Dopamine interacts
with D1 and D2-like GPCR receptors. The important difference
between D1 and D2-like receptors is their action on the
production of the secondary messenger cAMP. Due to the
coupling to the different types of G-proteins they either activate
(D1) or inhibit (D2) cAMP production (Klein et al., 2019).
Existing methods of dopamine measurements are not
well suited to detect changes of dopamine with both high
spatial and high temporal precision during complex animal
behavior. The widely used for dopamine measurements fast-scan
cyclic voltammetry allows to measure longitudinal changes of
dopamine in single recording locations, however, this technique
is invasive and restricts animals (Rodeberg et al., 2017).
Despite high temporal resolution of cyclic voltammetry, its
spatial resolution is low and does not allow visualization of
dopamine release from single neurons. Use of false fluorescent
neurotransmitters (FFN) allows to visualize dopamine release
with a single-neuron precision (Sames et al., 2013). However, it
requires intracranial infusion of FFN, and is not applicable for
longitudinal measurements (Dunn et al., 2018). In contrast, a
genetically encoded biosensor for dopamine allows to measure
dopamine transients in mice, zebrafish and flies with a high
spatiotemporal precision for months (Patriarchi et al., 2018;
Sun et al., 2018).
To engineer the intensiometric dopamine biosensor Sun
et al. (2018). inserted cpEGFP in the third intracellular loop
of several human dopamine receptors. Among them, a D1-
cpEGFP chimera appeared to be the most promising. Changing
the position of cpEGFP insertion and mutagenesis of linker
residues led to the development of two biosensor variants,
DA1m and DA1h. Both variants demonstrated rapid (∼60 ms
for DA1m and ∼140 ms for DA1h) fluorescence increase
in response to dopamine. A reversibility of the response
was demonstrated by treatment with dopamine antagonist.
Dopamine biosensors DA1m and DA1h (also called together
GRABDA) were orthogonal to the cell signaling and did not
activate GPCR downstream pathways (Sun et al., 2018).
In another dopamine biosensor family, called dLight1,
cpEGFP was inserted in the human D1 receptor (Patriarchi
et al., 2018). The initial variant, which was obtained by inserting
cpEGFP into the third loop of D1, showed a fluorescence
decrease in response to dopamine. To engineer a positive-
response biosensor Patriarchi et al. (2018) screened a library
of the D1-based mutants in HEK293 cells to select a dLight1.1
variant, which exhibited the highest fluorescence increase in
response to dopamine. An additional Phe129 mutation in the
GPCR part of dLight1.1 resulted in a dLight1.2 variant with even
higher dynamic range (Patriarchi et al., 2018).
Similar to GRABDA family, dLight1 biosensors do not
interfere with G-protein signaling and, unlike natural D1
receptor, do not stimulate cAMP synthesis. Thus, the conversion
of D1 to fluorescent biosensors blocked its ability to bind
G-protein and trigger signaling (Patriarchi et al., 2018).
Moreover, neither GRABDA nor dLight1 biosensors exhibit
internalization, which is inherent to dopamine receptors
(Sun et al., 2018).
SENSING NOREPINEPHRINE SIGNALING
Norepinephrine, also known as noradrenalin, is a
neurotransmitter that participates in the memory consolidation
of emotionally arousing experiences (Cahill and Alkire, 2003).
Norepinephrine is released by several brainstem nuclei including
locus coeruleus (LC, a nucleus in the pons of brainstem) and
is important for modulation of forebrain function. Release of
norepinephrine by LC is associated with waking in both the
cortex and hippocampus (Borodovitsyna et al., 2017).
Norepinephrine interacts with three types of adrenergic GPCR
receptors, such as α1, α2 and β1. Receptors α1 and β1 activate
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phospholipase C and adenylyl cyclase whereas α2 mostly exerts
inhibitory effect on cell signaling via suppression of adenylyl
cyclase activity (Ramos and Arnsten, 2007).
To develop an intensiometric biosensor for norepinephrine
Feng et al. (2019) inserted cpEGFP in the third intracellular loop
of several adrenergic receptors including α2AR. Among all tested
constructs, α2AR-cpEGFP preserved the membrane trafficking
and, therefore, was selected for further optimization. The
systematic truncation of the linker regions surrounding cpEGFP
resulted in the family of norepinephrine biosensors (Table 1)
consisting of GRABNE1m and GRABNE1h (Feng et al., 2019).
In another approach, a conformation-specific single-domain
nanobody was proposed to probe activation of β2-adrenoceptor.
The nanobody Nb80 recognizes β2AR only in its activated
form, so that upon activation of β2AR the Nb80-EGFP fusion
translocates from the cytoplasm to the plasma membrane.
However, this type of translocation biosensors is difficult to
implement in vivo (Irannejad et al., 2013).
All adrenergic receptors interact not only with norepinephrine
but also with structurally similar epinephrine (Ramos and
Arnsten, 2007). Thus, the development of norepinephrine-
specific GPCR-based biosensor seems problematic if not
impossible (Feng et al., 2018).
Bacteria are also able to sense norepinephrine. An example
of bacterial receptor of norepinephrine is the histidine
kinase QseC from enterohemorrhaghic E. coli strain. It
was shown that a response of QseC to norepinephrine was
blocked by norepinephrine antagonists (Clarke et al., 2006).
Moreover, a homology modeling revealed the presence of
typical for histidine kinases periplasmic signal-recognition
domain, which is responsible for the norepinephrine binding
(Clarke et al., 2006). Likely, use of this sensing domain
as norepinephrine-binding template could result in the
development of novel norepinephrine biosensors, similar to
GltI-based biosensors for glutamate.
OPIOID BIOSENSOR
Opioid receptors are GPCRs that are activated by endogenous
opioid peptides and exogenous compounds. They play a key
role in pain management, drug abuse and mood disorders.
There are three major subtypes of opioid receptors, such
as δ, µ, and κ (Shang and Filizola, 2015). Signaling of
opioid GPCRs is not limited to the cell plasma membrane
but to other cellular compartments (Irannejad et al., 2013)
including endosomes and Golgi membranes (Eichel and von
Zastrow, 2018). Studying opioid receptor signaling from
different cellular locations was problematic because of the
lack of relevant biosensors. To overcome this, Stoeber et al.
(2018) developed a nanobody-based fluorescent biosensor.
For that they selected a nanobody, which recognized only
activated opioid receptors, and fused it to EGFP (Stoeber
et al., 2018). This biosensor, called OR-sensor, allowed to
detect difference between activation of opioid receptors by
endogenous peptides and exogenous compounds, such as
drugs. It was found that the peptide agonists produce a
specific activation pattern initiated at the plasma membrane
and propagated to endosomes after receptor internalization
whereas drugs produce a different activation pattern by
additionally causing opioid receptor activation in Golgi apparatus
(Stoeber et al., 2018).
ATP BIOSENSORS
The function of the number of cellular metabolites depends on
their location. An example is ATP, which is universal intracellular
energy source and also a key purinergic signal that mediates
cell-to-cell communication both in and between organs. Thus,
targeting ATP biosensors to extracellular space allow to detect
purinergic transmission (Burnstock, 2006).
This approach was implemented with an ATeam ratiometric
biosensor for ATP. ATeam family of intracellular biosensors was
the first developed by an Imamura group (Conley et al., 2017).
These biosensors are composed of an ε subunit from a bacterial
FoF1-ATP synthase that is inserted between ECFP and EYFP.
ATP binding induces a conformational change that increases
FRET between the ECFP donor and EYFP acceptor. Targeting
ATeam3.10 using an immunoglobulin K leader sequence and a
transmembrane anchor domain from the PDGFR to a surface of
the plasma membrane turns it into an extracellular biosensor.
Similarly, an ε subunit of FOF1-ATPase from Bacillus PS3
was used to develop an intensiometric biosensor iATPSnFR.
In this biosensor, cpEGFP is inserted between two α-helices
of the ε subunit using two amino acid linkers from each side
with expectation that conformational changes of the ε subunit
might affect fluorescence. Both linkers were extensively mutated
to maximize ATP-dependent fluorescence changes. To optimize
expression of biosensor variants on the surface of HEK293 cells,
EGFP was replaced with sfGFP and additionally mutated to
reduce biosensor dimerization. The resulting iATPSnFR ATP
biosensor exhibited efficient cell surface trafficking and 25%1F/F
(Lobas et al., 2018).
BIOSENSOR FOR GLYCINE
Glycine acts as inhibitory neurotransmitter through ionotropic
glycine receptors and as co-agonist of excitatory glutamate
receptors of the NMDAR subtype. Recently, the first FRET-
based glycine biosensor GlyFS was developed. For this, Zhang
et al. (2018) used the Atu2422 protein from Agrobacterium
tumefaciens. Atu2422 binds glycine, serine and GABA; however,
rational design of the Atu2422 binding site allowed to
significantly increase its specificity to glycine. A glycine-specific
mutant of Atu2422, called AYW, was inserted between EGFP
and mVenus FPs. The ratiometric response of this initial EGFP-
AYW-mVenus construct to glycine was only 4%. To enhance
it, Zhang et al. (2018) truncated the flexible linker between
the AYW and EGFP and introduced a rigid (EAAAK)4 linker
between AYW and mVenus. These modifications led to the
increase of the dynamic range to 28%. Further elongation of
the rigid linker caused the decrease of FRET efficiency. The
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resulting GlyFS biosensor was applied to detection of glycine
transients in hippocampal acute slices. Since targeting of the
GlyFS to the cell surface using immunoglobulin K leader
sequence was ineffective, the biotin-streptavidin interaction
was utilized. For that, acute brain slices were biotinylated,
and the purified from expressing bacteria GlyFS biosensor
with streptavidin was injected into the slices. Likely, use of
the alternative membrane surface targeting peptides could
result in the GlyFS delivery to the cell surface. Also, further
engineering of glycine-binding AYW core could result in
the development of an intensiometric glycine biosensor, as
exemplified by use of GltI in both FRET and single-FP biosensors
for glutamate (Table 1).
WORKFLOW FOR ENGINEERING OF
BIOSENSORS FOR
NEUROTRANSMITTERS
Modern biosensors for glutamate, GABA, acetylcholine,
dopamine and glycine (Table 1) provide examples of the
successful development of biosensors. Based on their engineering
steps, we provide below the general workflow for development
of biosensors for neurotransmitters and neuromodulators. The
workflow consists of 4 steps outlined in Figure 3.
Step 1, an appropriate neurotransmitter or neuromodulator
binding protein should be chosen. It can be VFTD or GPCR. As
it was showed in engineering of biosensors for GABA (Marvin
et al., 2019) and glycine (Zhang et al., 2018), a specificity of
the selected sensing protein can become a problem. Natural
Atu2422 protein binds both GABA and glycine, so that it is not
possible to immediately use it for a biosensor specific to one of
these neurotransmitters. Therefore, Zhang et al. (2018) mutated
amino acid residues in the ligand-binding center of Atu2422
that resulted in a glycine-specific Atu2422 mutant, named AYW
(Figure 3). Atu2422 sensing domain has been considered for
GABA biosensor too, however, its low specificity prompted
Marvin et al. (2019) to search for other GABA-binding proteins.
That search resulted in the identification of Pf622 that interacts
with GABA only (Marvin et al., 2019).
Step 2, the selected specific neurotransmitter or
neuromodulator binding protein can be fused with either a
cpFP or a FRET pair of monomeric FPs. For ratiometric FRET-
based biosensors, this VFTD-containing sensing PBP is inserted
between two FPs. For intensiometric biosensors, the cpFP is
inserted in a flexible part of the VFTD-containing PBP, such as
GltI in iGluSnFr (Marvin et al., 2013) or Pf622 in iGABASnFr
(Marvin et al., 2019) biosensors. For both ratiometric and
intensiometric GPCR-based biosensors, an insertion-point for
FRET pair or cpFP is the same; it is the third intracellular loop
that undergoes the most pronounced conformational changes
upon GPCR activation.
Step 3, to efficiently report neurotransmitter changes several
properties of the biosensor prototype obtained in the previous
step should be improved. Fusing the neurotransmitter or
neuromodulator binding protein with FRET pair or cpFP
usually results in a biosensor variant with low dynamic range
of FRET or fluorescence intensity changes upon binding
the relevant substance. To improve dynamic range, a length
and a composition of the linkers connecting FPs with the
neurotransmitter-sensing domain (either VFTD or GPCR)
should be modified by length and contents using either structure-
based or random mutagenesis. For FRET-biosensors the linkers
should provide an efficient separation of FPs in the non-bound
state and optimally position FPs for high FRET in the bound
state. For example, in GlySF glycine biosensor replacement of
the flexible linker between AYW and FPs with the rigid helical
linker (EAAAK)4 resulted in the sevenfold increase of dynamic
range (Zhang et al., 2018). In other cases linkers were either
subjected to random mutagenesis followed by screening, as in the
dopamine biosensors (Feng et al., 2018; Patriarchi et al., 2018) or
modified by stepwise deletions of amino acid residues, as in the
acetylcholine biosensor (Jing et al., 2018).
Step 4, the resulting biosensors with high dynamic range
can be subjected to several types of optimizations to improve
parameters, such as color, stability, affinity and rate. Many
intensiometric biosensors contain circular permutants of GFP,
which can be changed to other FPs. For example, the cpsfGFP-
based glutamate biosensor SF-iGluSnFR was converted into blue,
cyan and yellow biosensors (Marvin et al., 2018) by introducing
chromophore-modifying mutations in cpsfGFP (Figure 3).
Changing cpEGFP in iGluSnFR to cpmApple resulted in the
red glutamate biosensors R-iGluSnFR1 and R-ncpiGluSnFR1
(Wu et al., 2018). An ability of biosensor to monitor fast
dynamics of neurotransmitter in synaptic cleft can be improved
by manipulating of binding affinity to neurotransmitter in
the sensing protein by mutating a ligand-binding site of
the respective VFTD. For example, the decrease of affinity
resulted in the development of fast glutamate biosensors,
such as iGlu (Helassa et al., 2018) and SF-iGluSnFR/S72A
(Marvin et al., 2018).
APPLICATION OF NEUROTRANSMITTER
BIOSENSORS IN VIVO
Correlation of real-time neuronal activity with corresponding
psychophysiological activities is one of the primary goals
of neuroscience (Alivisatos et al., 2013). Since chemical
transmission is the major communication pathway between
neurons, precise detection of chemical transmission
in neural circuits is required for achieving this goal.
Chemical point-to-point transmission occurs extremely
fast: depolarization of the post-synaptic neuron occurs
within hundreds of milliseconds after glutamate release in
the synaptic cleft. Chemical transmission underlies both
unconscious and conscious behavior. Experimental objects
perform complex psychophysiological tasks in 50–200 ms
whereas perception of conscious experience requires 0.5–2 s
(Korf and Gramsbergen, 2007).
Traditional molecular imaging methods, such as magnetic
resonance imaging (MRI), proton MR spectroscopy (HMRS),
and positron emission tomography (PET), has insufficient
spatiotemporal resolution to efficiently visualize these fast events
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FIGURE 3 | Workflow for engineering of biosensors. (1) Selection of a protein template, which interacts with the respective neurotransmitter or neuromodulator. From
left to right: specific templates that bind relevant chemical substance with high specificity, such as GPCRs, GltI from Escherichia coli or Pf622 from Pseudomonas
fluorescens. A promising template, such as Atu2422 from Agrobacterium tumefaciens that binds glycine, GABA and L-serine is also shown. Atu2422 mutant AYW
binds only glycine and is used in glycine biosensor (Zhang et al., 2018). (2) Fusing of neurotransmitter-binding protein templates with FRET pairs of FPs or cpFPs.
From left to right: Glycine-binding AYW is inserted between ECFP and mVenus; cpEGFP is inserted in the flexible region of GltI (Hires et al., 2008). FRET pair or cpFP
is inserted in the third intracellular loop of GPCRs. Note the low dynamic range of relevant fusions. (3) Improving dynamic range of the initial fusions. (3.1) Deleting the
flexible regions between ECFP and AYW in GlySF biosensor and inserting the rigid helical linker between AYW and mVenus (3.2) Mutagenesis of linkers joining VFTD
domain and cpEGFP in a biosensor. (3.3 and 3.4) Mutagenesis of regions of the third intracellular loop of GPCRs in the point of insertion of FRET pair or cpFP. (4)
Optimization of properties of resulting biosensors with high dynamic range. Manipulating color, stability and response dynamics. (4.1) Mutations, which change color
of EGFP to yellow (mVenus), cyan (mTurquoise) and blue (mAzurite) are introduced in the cpEGFP-based biosensor to get a set of multicolor biosensors (Marvin et al.,
2018). (4.2) EGFP is changed to mApple to get novel red fluorescent biosensor (Wu et al., 2018). (4.3) EGFP is changed to sfGFP to enhance biosensor stability. (4.3)
Lowering affinity of the neurotransmitter-binding protein to the neurotransmitter allows to get biosensors able to detect fast neurotransmitter transients (Helassa et al.,
2018; Marvin et al., 2018). (4.3) Enhancing affinity of neurotransmitter-binding protein allows to increase biosensor sensitivity to neurotransmitter (Marvin et al., 2018).
of chemical transmission. For example, PET has temporal
resolution of few minutes and spatial resolution of few
millimeters (Liang et al., 2015). Moreover, these techniques
do not allow imaging of single neurons and separate neural
circuits. However, spatially-precise longitudinal detection of fast
neurotransmitter transients in the animal brain can be performed
using modern optical techniques.
Setups for in vivo Experiments
Design of in vivo experiment with fluorescent biosensors
for neurotransmitters and neuromodulators, consists of a
transduction of the relevant brain zone with adeno-associated
virus (AAV) encoding a biosensor under specific promoters. AAV
injection can be performed intravenously via either tail injection
or using stereotactic injection, which requires surgery. Tail
injection allows to achieve even AAV distribution in the rodent
brain whereas stereotactic injection leads to expression of the
neurotransmitter only at the injection place (Figure 4A; Boulaire
et al., 2009; Stoica et al., 2013). In the case of tail injection a tissue-
specific promoter is important to limit biosensor expression to
certain tissue or subset of cells.
Common way to achieve neuron-specific biosensor expression
is use of specific promoters, such as human Synapsin1 (hSyn1)
promoter or CaMKII promoter (Kugler et al., 2003). Synapsin1
promoter ensures efficient neuronal targeting without expression
in glial cells (Kugler et al., 2003). If expression of biosensor in
glial cells is desirable then glial fibrillary acidic protein (GFAP)
promoter can be used (Dashkoff et al., 2016).
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FIGURE 4 | Expression of biosensors in vivo. (A) Delivery of biosensors to the
animal brain using AAV particles. A typical structure of the AAV vector is
shown (top). AAV transduction in adult animals can be performed by either
stereotactic injection in the brain or tail injection (middle). Brain injection
requires the stereotactic surgery, and the biosensor expression is restricted to
the injection point. Via tail injection AAV are delivered to the whole body. The
neuronal-specific promoters, such as for CaMKII kinase and Synapsin,
provide biosensor expression in CNS (Stoica et al., 2013). Use of cell-specific
Cre recombinase expression and AAV in which gene of biosensor is inverted
and flanked with loxP and lox511 sequences allows to achieve cell-specific
biosensor expression (bottom) (B) Generation of transgenic animals allows to
achieve either even or cell-specific expression of biosensor in the animal brain
(Xie et al., 2016).
Some promoters are able to limit transgene expression to
one type of neurons only. For example, Hb9 promoter limits
biosensor expression to motor neurons (Lukashchuk et al., 2016).
mDlx enhancer placed before the minimal AAV promoter
restricts transgene expression to GABAergic neurons
(Dimidschstein et al., 2016; Wilson et al., 2017), and Vglut2
promoter restricts transgene expression to glutamatergic
neurons (Borgius et al., 2010). For detailed description of the
relevant neuronal-specific promoters we refer readers to several
reviews (Shevtsova et al., 2005; Hioki et al., 2007; Delzor et al.,
2012; Dashkoff et al., 2016).
Generation of a transgenic animal line is another way to
achieve cell-specific biosensor expression in the mammalian
brain (Figure 4B; McGirr et al., 2017). Biosensor expression
is defined to the specific subset of neurons if mice with
cell-specific expression of Cre recombinase are used. In this
case, mice are injected with AAV in which the biosensor
encoding sequence is inverted and flanked with loxP and
lox511 sequences (Figure 4A; bottom). Cre recombinase
recognizes the lox sequences, excises and inverts the biosensor
gene. For example, expressing Cre recombinase under the
glutamatergic neurons specific Vglut2 promoter allows to confine
the gene expression to the excitatory glutamatergic neurons
(Borgius et al., 2010).
Delivery of biosensor can be followed by the visualization of
transmitter-specific events in the brain of behaving animals with
2P microscopy, miniaturized head-mounted microscopes or fiber
photometry (Figure 5; Helmchen et al., 2001; Guo et al., 2015;
Brunert et al., 2016; Ozbay et al., 2018).
When choosing how image acquisition should be performed,
two important issues should be considered. If study is performed
in immobilized animals, then imaging can be done using a
stationary 2P microscope. The 2P microscopy can be performed
via two types of imaging windows. In one type, a thin-skull
window technique is used in which the skull is thinned down
to a thickness of ∼15 µm. In another type, a part of skull is
removed and a glass cranial window is places instead (Figure 5A).
Both window techniques have advantages and disadvantages.
The thinned-skull window is less invasive and allows immediate
chronic imaging after surgery and long imaging intervals. Open-
skull window allows imaging of deep brain layers (Yang et al.,
2010). Thinned-skull and open-skull window techniques are
compared in details in several reviews (Yang et al., 2010;
Isshiki and Okabe, 2014).
If detection of neurotransmitter transients in freely behaving
animals is desirable, then a miniaturized head-mounted
microscope or a fiber photometry can be used (Figures 5B,C).
A number of miniaturized devices has been developed by
different research groups (Aharoni et al., 2019). While usually a
miniaturized microscope is connected with the detection device
using an optical fiber, wireless microscopes became recently
available too (Liberti et al., 2017). In contrast to single-photon
head-mounted microscopes that frequently require invasive
brain surgery for inserting optical objectives or prisms in
the brain, 2P miniaturized microscopes allow non-invasive
deep-brain imaging via thinned skull or, with limited skull
surgery, via cranial window (Silva, 2017). Moreover, modern 2P
head-mounted microscopes allow high-resolution imaging of
cortex with visualization of individual dendrites and dendritic
spines (Silva, 2017; Ozbay et al., 2018).
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FIGURE 5 | Detection and imaging of neuronal activity in vivo. (A) 2P excitation microscopy of immobilized animals. Principle of the 2P excitation is depicted (top).
Non-invasive 2P imaging of the brain in immobilized animals through the cranial window (middle) and through the thinned skull (bottom) is shown. (B) Schematics of
the portable single-photon microscope for imaging of neurotransmission in freely moving animals. Imaging data can be transferred to the detection device using
either optical fiber or wirelessly. (C) Schematics of the fiber photometry setup for detection in freely moving animals. Optical fiber is implanted in the animal brain.
Optical modulator determines excitation light frequency. Fluorescent signal from biosensor is collected with the same frequency using photodetector and normalized
to a signal at times when excitation light is turned off (Resendez and Stuber, 2015).
Similarly to miniaturized microscopes, a fiber photometry
(Figure 5C) enables detection of fluorescence in the brain
of freely moving animals. However, it requires implantation
of an optical fiber in the animal brain and, opposed to
the above microscopy approaches, lacks single-cell resolution.
Nevertheless, simplicity of fiber photometry instrumentation
and high sensitivity of detection of neuronal activities makes it
attractive to researchers (Resendez and Stuber, 2015). Multicolor
fiber photometry is also available, allowing readout of several
biosensors simultaneously. Moreover, a wireless fiber photometry
was recently developed to detect biosensor responses in the brain
of non-tethered animals (Lu et al., 2018).
Examples of Applications of Biosensors
for Neurotransmitters
Biosensors for neurotransmitters are used in animals in a wide
range of studies, from simple responses to sensory stimuli to
complex animal behaviors in models of mood disorders.
Mapping Neurotransmitter Transients in Cortex of
Behaving Animals
Neurotransmitter biosensors allow precise spatiotemporal
mapping of neurotransmission in the brain of animals. For
example, Xie et al. (2016) used iGluSnFR to determine high-
frequency mesoscale intracortical maps. In this study iGluSnFR
enabled to resolve temporal features of sensory processing in both
anesthetized and awake mice. The fast glutamate transmission
events on 13–200 ms timescale in response to sensual stimuli,
such as touching whiskers, skin on the fore- and hind limbs, and
visual stimuli, were imaged (Figure 6A; Xie et al., 2016).
iGluSnFR was also used to localize task-specific glutamate
events in the primary motor cortex of mice. iGluSnFR was
delivered to the mouse motor cortex using AAV particles, and the
brain of mice was imaged in rest and upon running (while head of
running mice was fixed). It was found that in the brain of resting
mice the repetitive glutamate transients are observed in dendritic
spines. Running increased frequency of these events twice over
8 s of running. Extremely high spatiotemporal resolution in
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FIGURE 6 | Visualization of neurotransmitter transients in vivo. (A) Mapping glutamate transients in the mouse brain is performed through the chronic cranial
window. One millisecond light visual stimulation induces an initial fast response followed by a clearly separated secondary response in awake Emx-CaMKII-iGluSnFR
mouse (Xie et al., 2016). (B) Complex song learning in zebra finches is outlined. Left: juvenile zebra finch is exposed to the living adult male tutor. The song causes
dopamine bursts in the high vocal center (HVC) of the juvenile bird, resulting in song learning. Right: juvenile zebra finch is exposed to the playback of the song.
Dopamine bursts in the HVC of juvenile bird are not detected, and consequently, song learning does not occur (Tanaka et al., 2018). (C) Spectral multiplexing of
green fluorescent dLight1.1 with either red fluorescent jRGECO1a biosensor or channelrhodopsin ChrimsonR activatable with red light. Left: both dopamine and
calcium signals are detected in the mouse brain using multicolor fiber photometry. The sucrose application causes both dopamine transients and neuronal activity in
the NAc (green and red squares), whereas the foot shock increases calcium but not dopamine transients (gray and red squares). Right: ChrimsonR
channelrhodopsin is selectively expressed in the VTA of the mouse brain. Activation of ChrimsonR with red light causes the dopamine release in the NAc. The VTA
neuron projections to NAc are shown with the arrow.
this study demonstrates the utility of iGluSnFR for the precise
mapping of glutamate release events (Marvin et al., 2013).
Complex Song Learning in Zebra Finches
Juvenile zebra finches copy songs of the living bird adult
tutors only if they interact with them and fail to reproduce
songs played to them through a speaker (Figure 6B). To
elucidate how juvenile birds detect a difference between the
tutor and speaker Tanaka et al. (2018) expressed intensiometric
dopamine biosensor GRABDA1h in the neurons of high vocal
center (HVC) and imaged dopamine transients using 2P
microscopy. He has found that only interaction with the song
of live tutor caused dopamine secretion by the neurons of
the periaqueductal gray (PAG). Even playback of the song
from the recent tutor failed to evoke similar activity. Thus,
the single-FP neurotransmitter biosensor allowed to visualize
dopamine transients with the single-neuron precision and to
establish connection between dopamine secretion by the PAG
neurons and transmission of vocal behaviors from one bird to
another (Tanaka et al., 2018).
In the same study the PAG neurons were excited
optogenetically using ChR2 channelrhodopsin actuator
expressed in the HVC. Interestingly, the excitation of the
HVC neurons via ChR2 in combination with playback of the
song from the speaker resulted in the successful learning by
juvenile birds (Tanaka et al., 2018). Dopamine blockers reduced
the effect. However, optogenetic excitation was not combined
with the simultaneous analysis of dopamine transients because
ChR2 is excited by the same light used for visualization of
EGFP-based biosensors.
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Multiplexing of dLight1.1 With Red-Light Excited
Probes
The availability of red fluorescent calcium biosensors and
red-shifted channelrhodopsins provides possibility either
to simultaneously detect neurotransmitter transients and
neuron activity or to combine optogenetic excitation of
certain neurons with detection of neurotransmitters released
by their terminals. Patriarchi et al. (2018) combined
visualization of dopamine transients with calcium imaging
using jRGECO1a red biosensor. It has been shown that
mice consuming water containing sucrose (reward) show
both dopamine and calcium peaks in the nucleus accumbens
(NAc) region. However, mice subjected to foot shock
demonstrated only calcium spikes in the NAc (Figure 6C;
Patriarchi et al., 2018).
In the same study dLight1.1 was combined with the
red-light excited channelrhodopsin ChrimsonR (Figure 6C).
Dopaminergic neurons in the ventral tegmental area (VTA)
send projections to the NAc. dLight1.1 was delivered in the
mouse brain using AAV particles, and ChrimsonR was selectively
expressed in the VTA. Photostimulation of neurons in the VTA
enabled detection of individual peaks of dopamine transients
in the NAc region.
Imaging Neurotransmission in Animal Behavioral
Models
Dysregulation of neurotransmission underlies the number of
brain diseases, making the biosensors useful in various animal
models of human neuropsychiatric disorders. The animal
models of human CNS disorders proved their effectiveness in
studies of Parkinsonism (Blesa and Przedborski, 2014), major
depressive disorder (Morozova et al., 2016; Zorkina et al., 2019),
autism (Chesselet, 2005) and many others reviewed elsewhere
(Keifer and Summers, 2016).
For example, the glutamate intensiometric biosensor
iGluSnFR was used to study antidepressant activities of
ketamine (McGirr et al., 2017). Transgenic mice expressing
iGluSnFR (Figure 4B) were subjected to social defeat model
of depression and then treated with ketamine. Glutamate
transients were imaged non-invasively using the thin-skull
window technique. Longitudinal tracking of iGluSnFR signal
revealed that social defeat caused the network-wide glutamate
functional hyperconnectivity in animals whereas injection of
ketamine reduces this effect.
In another study, the GRABDA biosensor for dopamine
was applied to detect endogenous dopamine release during
Pavlovian conditioning in immobilized and freely moving mice
(Feng et al., 2018). The water-restricted mice were trained to
associate a brief auditory cue with reward (a drop of water).
Monitoring fluorescence changes of GRABDA in these trained
animals allowed to visualize dopamine release in response
to the reward-predictive cue (sound). Also, the dopamine
biosensor was used to study dopamine dynamics during naturally
rewarding social behaviors, such as courtship and mating. It
was confirmed that introduction of the sexually receptive mouse
female into the home cage of the male promoted dopamine
release during mating.
Moreover, given the important role of dopaminergic
transmission in reward and pleasure behavior (Bressan and
Crippa, 2005) it will be advantageous to apply dopamine
biosensors in animal models of depression, similarly to iGluSnFR.
CONCLUSION
Recently developed fluorescent biosensors for glutamate,
dopamine, acetylcholine, adrenaline and GABA allow to
detect neuronal activity in vivo with high spatiotemporal
precision. Single-FP-based intensiometric biosensors represent
the most useful group of the biosensors because they are
monochromic and have the higher dynamic range than
FRET-based, thus, enabling spectral multiplexing with other
biosensors or optogenetic tools and imaging of neuronal activity
in vivo, respectively.
In spite of many advantages, there are two major limitations
of the biosensors for neurotransmitters and neuromodulators.
One limitation is that these biosensors may influence dynamics of
neurotransmitters and neuromodulators in the brain by binding
them. The similar problem and possible ways of its resolution
were recently described for calcium biosensors (McMahon and
Jackson, 2018). The other limitation is related to use of the
biosensors in the human brain. Although nervous system is
considered immunologically tolerant, but expression of proteins
from bacteria and invertebrates may cause immunological
response. Currently, expression of bacterial channelrhodopsins
is restricted to human eyes in vision restoration (Baker
and Flannery, 2018). However, heterologous expression of
bacterial proteins may become a subject of immunogenicity
(Maimon et al., 2018).
We foresee the following future directions in the development
and applications of biosensors for chemical transmission.
First, the major characteristics of the existing fluorescent
biosensors, such as selectivity, stability, sensitivity, kinetics,
reversibility and dynamic range (Shang and Filizola, 2015), will
be enhanced and optimized for specific applications in the
mammalian brain.
Second, the availability of the neurotransmitter- and
neuromodulator-binding proteins in unicellular and
multicellular organisms, including diverse bacterial ABC-
transporters (Moussatova et al., 2008), GABA-binding malate
transporters in plants (Ramesh et al., 2015), and monoamine-
binding transporters in worms (Ribeiro and Patocka, 2013),
allows to anticipate that they will be used as molecular templates
to engineer novel biosensors. Likely, search of these templates can
be alleviated using machine learning approaches, such as deep
learning. Machine learning is based on computer algorithms,
which are able to learn automatically to distinguish between
various datasets, for example, between two sets of images (Majaj
and Pelli, 2018). Deep machine learning is based on complex
multi-layered artificial neural networks (Miotto et al., 2018;
Mehta et al., 2019). Deep learning approaches are already used
to predict interaction of a chemical substance, like drug, with a
target protein. Likely, deep learning approaches for prediction of
drug-target interactions (Anusuya et al., 2018; Lee et al., 2019)
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and to annotate protein functions (Sureyya Rifaioglu et al., 2019)
can be adapted to predict interaction of neurotransmitters or
neuromodulators with proteins with unknown function. Thus,
novel specific neurotransmitter-binding proteins can be found
while limitations derived from use of GPCRs or finite number
of bacterial proteins used in biosensor engineering could be
overcome. Use of deep learning for identification of such proteins
in silico will reduce laborious and time-consuming search for
neurotransmitter-binding proteins in vitro.
Third, the available biosensors have fluorescence readout
mainly in the green range of light spectrum, with few
exceptions in the red range. We anticipate that more red
and, moreover, far-red and near-infrared fluorescent biosensors
for neurotransmitters will be developed based on the modern
red (Shcherbakova et al., 2015), far-red and near-infrared FPs
(Chernov et al., 2017; Oliinyk et al., 2017; Shcherbakova et al.,
2018). Far-red and near-infrared light is less cytotoxic, penetrates
animal tissues deeper, and exhibits less scattering. Moreover,
far-red and near-infrared biosensors will allow cross-talk free
simultaneous use of common optogenetic tools and major
calcium biosensors.
Fourth, we hypothesize that processing of the data obtained
in imaging experiments will benefit from deep learning methods.
Neurotransmitter and neuromodulator biosensors allow in vivo
detection of large neural populations during weeks with single-
neuron and single-spike resolution, similar to calcium biosensors
(Pnevmatikakis, 2019). Several deep learning-based techniques
for calcium imaging (Stringer and Pachitariu, 2019) can be
adopted for processing of data obtained in experiments with
neurotransmitter imaging. For example, an artificial neural
network STNeuroNet was recently used to identify and
segment active neurons expressing calcium biosensor (Soltanian-
Zadeh et al., 2019). Likely, the similar technologies will be
applied for analysis of large datasets of neurotransmitter and
neuromodulator imaging.
Fifth and last, much wider implementation of biosensors for
neurotransmitters and neuromodulators for mapping of brain
activity can be anticipated. Correlation between brain activities
and behavior makes possible prediction of motor or cognitive
functions out of imaging data (Li et al., 2019). Data obtained
by imaging of fluorescent biosensors for neurotransmitters and
neuromodulators in animal brain can also be used to predict
motor and cognitive function in animal models. For example,
calcium imaging data recorded by 2P microscopy in rodent brain
were used to predict features of upcoming movement (forelimb
reach) in mice. For that, the authors collected calcium imaging
signal from motor cortex while mice were performing a two-
dimensional lever reaching task. Obtained calcium imaging data
were used to train deep learning model to predict forelimb
movement direction in mice. This deep learning model was then
used to determine the motion direction based on imaging of
calcium in the motor cortex (Li et al., 2019). We hypothesize
that this approach can be expanded to the prediction of
motion direction out of neurotransmitter and neuromodulator
biosensor imaging. Such data can be further applied in
the field of brain-computer interface (Andersen et al., 2014;
Li et al., 2019).
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